BIM

111.4

-3.38%↓

BIM

111.4

-3.38%↓

BIM

111.4

-3.38%↓

BIM

111.4

-3.38%↓

BIM

111.4

-3.38%↓

Search

Orion Oyj (Class B)

Cerrado

46.6 -7.81

Resumen

Variación precio

24h

Actual

Mínimo

46.6

Máximo

48.92

Métricas clave

By Trading Economics

Ingresos

-128M

73M

Ventas

-37M

434M

P/B

Media del Sector

21.243

61.151

BPA

0.52

Rentabilidad por dividendo

3.11

Margen de beneficio

16.897

Empleados

3,880

EBITDA

136M

202M

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

3.11%

2.71%

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

1.7B

7.3B

Apertura anterior

54.41

Cierre anterior

46.6

Orion Oyj (Class B) Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

8 abr 2025, 22:42 UTC

Principales Movimientos del Mercado

Peabody Energy Shares Climb on Trump Executive Orders Boosting Coal Industry

8 abr 2025, 22:35 UTC

Ganancias
Principales Movimientos del Mercado

Cal-Maine Foods Shares Fall As Justice Dept Probes Egg Prices

8 abr 2025, 21:30 UTC

Ganancias

Cal-Maine Foods Cooperating With Justice Dept Probe Into Egg Price Increases -- Update

8 abr 2025, 21:21 UTC

Ganancias

Cal-Maine Foods Cooperating With Justice Dept Probe into Egg Price Increases

9 abr 2025, 00:00 UTC

Principales Noticias

Trump's Tariffs Put Fed Chair Powell in a 'No-Win Situation' -- WSJ

8 abr 2025, 23:45 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

8 abr 2025, 23:45 UTC

Charlas de Mercado

Nikkei May Fall Amid U.S. Tariff Uncertainty -- Market Talk

8 abr 2025, 23:43 UTC

Charlas de Mercado

Lithium Oversupply Weighs on Price Outlook -- Market Talk

8 abr 2025, 23:43 UTC

Adquisiciones, fusiones, absorciones

Woolworths' Rivals Have Other Options to Source Ready Meals, ACCC Says

8 abr 2025, 23:42 UTC

Charlas de Mercado

Gold Falls on Possible Unwinding of Long Positions to Raise Cash -- Market Talk

8 abr 2025, 23:42 UTC

Adquisiciones, fusiones, absorciones

Beak & Johnston Makes Ready Meals, Pastries for Wholesale, Retail

8 abr 2025, 23:41 UTC

Adquisiciones, fusiones, absorciones

Woolworths' Acquisition Unlikely to Have Substantial Anti-Competitive Effect, ACCC Says

8 abr 2025, 23:40 UTC

Adquisiciones, fusiones, absorciones

Australian Competition and Consumer Commission: Will Not Oppose Transaction

8 abr 2025, 23:39 UTC

Adquisiciones, fusiones, absorciones

Australian Competition Regulator to Allow Woolworths' Acquisition of Beak & Johnston

8 abr 2025, 23:21 UTC

Adquisiciones, fusiones, absorciones

U.S. Steel: $75 per Shr That the Ancora 'Plan' Proposes Is Really an Unrealistic, Distant Future Value Pipedream Rooted Firmly in Fiction >X

8 abr 2025, 23:21 UTC

Adquisiciones, fusiones, absorciones

U.S. Steel: Stockholders Should Be Very Skeptical of Ancora's 'Plan' or That Their Nominees Could or Would Vigorously Fight for the Nippon Steel Deal >X

8 abr 2025, 21:26 UTC

Principales Noticias

When Coffee Mate Made a 'White Lotus' Piña Colada Creamer, It Had No Idea How the Season Would End -- WSJ

8 abr 2025, 21:26 UTC

Ganancias

Pfizer Stock's Fall to '97 Level Lifts Yield Near 8%. Dividend Looks Safe. -- Barrons.com

8 abr 2025, 21:18 UTC

Adquisiciones, fusiones, absorciones

Peabody Energy: Remains in Conversation With Anglo Amer to Better Understand Impacts of Event, Preserving All Rights and Protections Under Purchase Agreements >BTU

8 abr 2025, 21:18 UTC

Adquisiciones, fusiones, absorciones

Peabody Energy: Following Ignition Event Last Week at Anglo Amer's Moranbah North Mine, Reviewing Options Related to Acquisition of Steelmaking Coal Assets From Anglo Amer >BTU

8 abr 2025, 21:06 UTC

Principales Noticias

Stocks Are in Turmoil, but Treasury Yields Are Stubbornly High -- Update

8 abr 2025, 20:50 UTC

Principales Noticias

Harley-Davidson Seeks New CEO, Facing Sales Slump and Tariffs -- 3rd Update

8 abr 2025, 20:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

8 abr 2025, 20:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

8 abr 2025, 20:49 UTC

Principales Noticias

Vanguard Cuts Forecast for U.S. Economy. Tariffs Have Us 'Dancing With Recession.' -- Barrons.com

8 abr 2025, 20:40 UTC

Ganancias

BYD Stock Soars. It's Catching Up to Tesla in Yet Another Way. -- Barrons.com

8 abr 2025, 20:28 UTC

Ganancias

Sandstorm Gold: Will Release 1Q Results on May 6 After Markets Close >SSL.T

8 abr 2025, 20:28 UTC

Ganancias

Sandstorm Gold: During Three Mos Ended March 31, Realized Record Preliminary Revenue of $50.1M (20,316 Attributable Gold Equivalent Ounces and $42.8M in Rev for the Comparable Period in 2024) >SSL.T

8 abr 2025, 20:28 UTC

Ganancias

Sandstorm Gold: Record Preliminary Total Sales, Royalties, Income From Other Interests of $54.1M for Three Mos Ended March 31 ($42.8M in Total Sales, Royalties, Income From Other Interests for Comparable Period in 2024) >SSL.T

8 abr 2025, 20:28 UTC

Ganancias

Sandstorm Gold: During Three Mos Ended March 31, Sold Approximately 18,500 Attributable Gold Equivalent Ounces >SSL.T

Comparación entre iguales

Cambio de precio

Orion Oyj (Class B) Esperado

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Orion Oyj (Class B)

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson's disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer. It also offers Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. In addition, the company provides veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; APIs for generic compounds and proprietary products, as well as contract manufacturing services; and markets and sells veterinary drugs manufactured by other international companies. It has partnership with Propeller Health to connect the Easyhaler(R) product portfolio; collaboration and option to license agreement with Abilita Therapeutics to develop innovative antibody therapeutics; and a research collaboration and license agreement with Amneal Pharmaceuticals, Inc. to commercialize Amneal's generic products. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.